Working Memory Training in Patients with Mild Cognitive Impairment
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: CogMed.
- Кому может быть актуально
- Состояния в реестре: Mild Cognitive Impairment (MCI). Базовые параметры: от 50 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- США
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
CogMed Intervention Targeting Working Memory in Patients with Mild Cognitive Impairment
Обзор
The purpose of this study is to test whether a special memory training program, called CogMed, can help people with early memory problems. The Investigators want to see if this training improves memory and also helps reduce stress. The Investigators also want to see if CogMed results in changes to a blood biomarker called p-Tau 217, which possibly indicate Alzheimer's disease (AD).
Подробное описание
The goal of this study is to conduct a pilot clinical trial aimed at comparing the effects of CogMed intervention plus Treatment As Usual (TAU) versus TAU alone in patients with Mild Cognitive Impairment (MCI). Based on our preliminary data from brain health program, the primary hypothesis is that the CogMed intervention may improve the CogMed measures and possibly working memory. This may improve sense of self-efficacy and lead to a decrease in perceived stress, thereby demonstrating possible transfer of cognitive benefits to biobehavioral construct of perceived stress. Additionally, the study aims to demonstrate the feasibility of collecting p-Tau 217, a blood based Alzheimer's Disease biomarker, from MCI patients. Though no significant changes in pTau 217 are expected due to the short duration of the study, the goal is to successfully recruit 10 MCI patients (5 in the intervention group and 5 in the control group) who are willing to undergo blood draws for p-Tau 217 level determination.
Вмешательства
- Другое CogMed
CogMed which is a computerized working memory training program developed by Karolinska University.
Первичные конечные точки
- Working Memory as measured by the WAIS-IV Digit Span Forward/Backward [Срок оценки: Will be assessed at baseline and again at a 3-month follow-up following the intervention period.]
- Working Memory as measured by the TMT-B [Срок оценки: Will be assessed at baseline and again at a 3-month follow-up following the intervention period.]
- Working Memory as measured by Category Fluency Test [Срок оценки: Will be assessed at baseline and again at a 3-month follow-up following the intervention period.]
Вторичные конечные точки (11)
- Change in Blood biomarker [Срок оценки: Will be assessed at baseline and again at a 3-month follow-up following the intervention period.]
- Perceived Stress Scale (PSS) Score [Срок оценки: Will be assessed at baseline and again at a 3-month follow-up following the intervention period.]
- Brief Resilience Scale (BRS) Score [Срок оценки: Will be assessed at baseline and again at a 3-month follow-up following the intervention period.]
- Pittsburgh Sleep Quality Index (PSQI) Score [Срок оценки: Will be assessed at baseline and again at a 3-month follow-up following the intervention period.]
- Physical Activity and Sedentary Behavior Questionnaire Score [Срок оценки: Will be assessed at baseline and again at a 3-month follow-up following the intervention period.]
- Mediterranean Diet Scale(MedDiet) [Срок оценки: Will be assessed at baseline and again at a 3-month follow-up following the intervention period.]
- WHO Quality of Life Questionnaire [Срок оценки: Will be assessed at baseline and again at a 3-month follow-up following the intervention period.]
- Memory as measured by the Comprehensive Trail Making Test (CTMT) [Срок оценки: Will be assessed at baseline and again at a 3-month follow-up following the intervention period.]
- Cognitive Impairment as measured by the Mini Mental State Examination (MMSE) [Срок оценки: Will be assessed at baseline and again at a 3-month follow-up following the intervention period.]
- Verbal Memory as Measured by the Auditory Verbal Learning Test (AVLT) [Срок оценки: Will be assessed at baseline and again at a 3-month follow-up following the intervention period.]
- Comprehensive Assessment of Acceptance and Commitment Therapy Process (CompACT) [Срок оценки: Will be assessed at baseline and again at a 3-month follow-up following the intervention period.]
Критерии участия
Критерии включения
- Male or female outpatients ages ≥ 50 years;
- Meet Mayo Clinic Criteria for MCI. (Patients with mild cognitive impairment)
- Access to the internet through computer
- A proficiency in speaking and reading English or having a family member who is proficient in reading and speaking English and is willing to serve as a translator.
- Vision and hearing must be sufficient to comply with study procedures.
Критерии исключения
- Mini Mental State Exam (MMSE) score less than 19 or patients diagnosed with moderate or severe dementia by a clinician.
- In the opinion of the investigator, participation would not be in the best interest of the subject.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Рандомизированное
- Модель
- Параллельные группы
- Маскирование
- Простое слепое
- Основная цель
- Другое
Центры проведения
США · 1 центр
- Barrow Neurological Institute, Division of Alzheimer's Disease — Phoenix
Публикации
- Apiquian R, Diaz R, Victoria G, Ulloa RE. The Category Fluency Test components and their association with cognition and symptoms in adolescents with schizophrenia. Schizophr Res Cogn. 2023 Nov 10;35:100296. doi: 10.1016/j.scog.2023.100296. eCollection 2024 Mar. PMID 38025823
- Kortte KB, Horner MD, Windham WK. The trail making test, part B: cognitive flexibility or ability to maintain set? Appl Neuropsychol. 2002;9(2):106-9. doi: 10.1207/S15324826AN0902_5. PMID 12214820
- Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998 May;28(3):551-8. doi: 10.1017/s0033291798006667. PMID 9626712
- Flak MM, Hol HR, Hernes SS, Chang L, Engvig A, Bjuland KJ, Pripp A, Madsen BO, Knapskog AB, Ulstein I, Lona T, Skranes J, Lohaugen GCC. Adaptive Computerized Working Memory Training in Patients With Mild Cognitive Impairment. A Randomized Double-Blind Active Controlled Trial. Front Psychol. 2019 Apr 12;10:807. doi: 10.3389/fpsyg.2019.00807. eCollection 2019. PMID 31031677
- Wilson, K. G., Sandoz, E. K., Kitchens, J., & Roberts, M. E. (2010). "The Valued Living Questionnaire: Defining and measuring valued action within a behavioral framework." The Psychological Record 60: 249-272
- Reynolds, C. R. (2002). Comprehensive trail-making test : examiner's manual. Austin, Tex., Pro-Ed
- Rey, A. (1964). L'examen clinique en psychologie. Paris, Presses Universitaires de France
- Francis, A. W., D. L. Dawson and N. Golijani-Moghaddam (2016). "The development and validation of the Comprehensive assessment of Acceptance and Commitment Therapy processes (CompACT)." Journal of Contextual Behavioral Science 5(3): 134-145
Идентификаторы
NCT: NCT06734286 · 24-500-385-30-53